Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Nevirapine 50mg/5ml oral suspension |
| BNF code | 0503010B0AAABAB |
| Virtual Therapeutic Moiety | Nevirapine |
| Date identifier became valid | 9 May 2023 |
| Previous product identifier | 324865007 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 5.000 |
| Unit dose form units | ml |
| Unit dose unit of measure | spoonful |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Nevirapine hemihydrate |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 386898005 |
| Strength value numerator | 10.000 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | suspension.oral |
| Dose Form | |
| Formulation | Oral suspension |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd) | |
| Virtual Medicinal Product Packs | |
| Nevirapine 50mg/5ml oral suspension 240 ml | |
dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.